(Q41719486)

8 October 2017

1 reference

title

Matrix metalloproteinases and diseases of the CNS (English)

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

12 December 2024

1

V. W. Yong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9498303

12 December 2024

author name string

C. A. Krekoski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9498303

12 December 2024

P. A. Forsyth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9498303

12 December 2024

R. Bell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9498303

12 December 2024

D. R. Edwards

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9498303

12 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9498303

12 December 2024

publication date

1 February 1998

1 reference

8 October 2017

February 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9498303

full work available at URL

12 December 2024

https://api.elsevier.com/content/article/PII:S0166223697011697?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

https://api.elsevier.com/content/article/PII:S0166223697011697?httpAccept=text/plain

12 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

12 December 2024

published in

Trends in Neurosciences

1 reference

8 October 2017

volume

21

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

75-80

1 reference

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Characterization of Neutral Proteinases from Alzheimer-Affected and Control Brain Specimens: Identification of Calcium-Dependent Metalloproteinases from the Hippocampus

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Gelatinase A not alpha-secretase?

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Tumor cell interactions with the extracellular matrix during invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Chondroitin 4-sulfate proteoglycan forms an extracellular network in human and rat central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

The Metalloproteinase Stromelysin-1 (Transin) Mediates PC12 Cell Growth Cone Invasiveness through Basal Laminae

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

7 January 2021

12

50

2322

Apodaca

1990

1 reference

https://api.crossref.org/works/10.1016/S0166-2236(97)01169-7

12 December 2024

Identifiers

1 reference

8 October 2017

1 reference